These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 10027817)
1. Adenoviral gene transfer of the human V2 vasopressin receptor improves contractile force of rat cardiomyocytes. Laugwitz KL; Ungerer M; Schöneberg T; Weig HJ; Kronsbein K; Moretti A; Hoffmann K; Seyfarth M; Schultz G; Schömig A Circulation; 1999 Feb; 99(7):925-33. PubMed ID: 10027817 [TBL] [Abstract][Full Text] [Related]
2. Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. Weig HJ; Laugwitz KL; Moretti A; Kronsbein K; Städele C; Brüning S; Seyfarth M; Brill T; Schömig A; Ungerer M Circulation; 2000 Apr; 101(13):1578-85. PubMed ID: 10747352 [TBL] [Abstract][Full Text] [Related]
3. Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility. Laugwitz KL; Weig HJ; Moretti A; Hoffmann E; Ueblacker P; Pragst I; Rosport K; Schömig A; Ungerer M Circ Res; 2001 Apr; 88(7):688-95. PubMed ID: 11304491 [TBL] [Abstract][Full Text] [Related]
5. Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction. Izumi Y; Nakayama Y; Memetimin H; Inoue T; Kohda Y; Nonoguchi H; Tomita K Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1170-6. PubMed ID: 18701631 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. Drazner MH; Peppel KC; Dyer S; Grant AO; Koch WJ; Lefkowitz RJ J Clin Invest; 1997 Jan; 99(2):288-96. PubMed ID: 9005997 [TBL] [Abstract][Full Text] [Related]
7. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Juul KV; Bichet DG; Nielsen S; Nørgaard JP Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801 [TBL] [Abstract][Full Text] [Related]
8. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist. Serradeil-Le Gal C Adv Exp Med Biol; 1998; 449():427-38. PubMed ID: 10026834 [TBL] [Abstract][Full Text] [Related]
9. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. Zhang J; Sato M; Duzic E; Kubalak SW; Lanier SM; Webb JG Am J Physiol; 1997 Aug; 273(2 Pt 2):H971-80. PubMed ID: 9277517 [TBL] [Abstract][Full Text] [Related]
10. Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes. Borst MM; Szalai P; Herzog N; Kübler W; Strasser RH Cardiovasc Res; 1999 Oct; 44(1):113-20. PubMed ID: 10615395 [TBL] [Abstract][Full Text] [Related]
11. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene. Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381 [TBL] [Abstract][Full Text] [Related]
12. Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells. Pinto CS; Reif GA; Nivens E; White C; Wallace DP Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1412-24. PubMed ID: 22952279 [TBL] [Abstract][Full Text] [Related]
13. Functional role of the NPxxY motif in internalization of the type 2 vasopressin receptor in LLC-PK1 cells. Bouley R; Sun TX; Chenard M; McLaughlin M; McKee M; Lin HY; Brown D; Ausiello DA Am J Physiol Cell Physiol; 2003 Oct; 285(4):C750-62. PubMed ID: 12801889 [TBL] [Abstract][Full Text] [Related]
14. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. Rybin VO; Xu X; Lisanti MP; Steinberg SF J Biol Chem; 2000 Dec; 275(52):41447-57. PubMed ID: 11006286 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist. Makita N; Sato T; Yajima-Shoji Y; Sato J; Manaka K; Eda-Hashimoto M; Ootaki M; Matsumoto N; Nangaku M; Iiri T J Biol Chem; 2016 Oct; 291(43):22460-22471. PubMed ID: 27601473 [TBL] [Abstract][Full Text] [Related]
17. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Zhu X; Gilbert S; Birnbaumer M; Birnbaumer L Mol Pharmacol; 1994 Sep; 46(3):460-9. PubMed ID: 7935326 [TBL] [Abstract][Full Text] [Related]
18. β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling. Tilley DG; Zhu W; Myers VD; Barr LA; Gao E; Li X; Song J; Carter RL; Makarewich CA; Yu D; Troupes CD; Grisanti LA; Coleman RC; Koch WJ; Houser SR; Cheung JY; Feldman AM Circulation; 2014 Nov; 130(20):1800-11. PubMed ID: 25205804 [TBL] [Abstract][Full Text] [Related]
20. Specific activation of adenylyl cyclase V by a purinergic agonist. Pucéat M; Bony C; Jaconi M; Vassort G FEBS Lett; 1998 Jul; 431(2):189-94. PubMed ID: 9708900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]